Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Novartis, Ionis Team Up Again In Cardiovascular Disease

Aug 03 2023

• By Joseph Haas

Deal Watch 2021 — • Source: Shutterstock

Related Content

GSK Acquires Conjugated Vaccine Expertise With GlycoVaxyn Purchase

Feb 11 2015

Finance Watch: The Job Cuts Keep Coming As Companies Try To Conserve Cash

Aug 16 2022

Pfizer’s Buying Spree Continues With GBT, Gaining A Sickle Cell Disease Franchise

Aug 08 2022

ESMO: Ayala In Shadow Of SpringWorks In Rare Cancer Race

Sep 13 2022

Deal Watch: Jazz Breaks Into Immuno-Oncology Via Licensing Pact With Werewolf

Apr 07 2022

EryDex shows Phase II promise for rare disease ataxia telangiectasia

Mar 02 2012

Novartis Spreads Cardiovascular Bets with Ionis Antisense Option Deal

Jan 06 2017

Deal Watch: Pfizer Licenses Skin-Targeted JAK Inhibitor Portfolio From Theravance

Jan 02 2020

Deal Watch, Licensing & Alliances: Amgen Places $66m Bet On Genetic Sequencing

Oct 19 2018

Revolution Picks Up Remains Of EQRx In All-Stock Deal

Aug 01 2023

TG Therapeutics Briumvi Deal Fails To Impress The Market

Aug 02 2023

Fast-Growing AstraZeneca Brushes Off China Rumors And Dato-DXd Concerns

Jul 28 2023

Biogen Buys Time For Leqembi Ramp-Up With Reata Acquisition

Jul 28 2023

Roche CEO Outlines M&A Criteria

Jul 28 2023

AbbVie To Build On Relationship With Calibr Via Five-Year Extension

Jul 26 2023

Reading The FTC Tea Leaves: Investors Await Insights For M&A

Jul 26 2023

Galapagos Sees Global Market For Point-Of-Care CAR-T But Is Still On M&A Trail

Jul 25 2023

Eyebrows Raised As Roche Inks Cardiovascular Pact With Alnylam

Jul 24 2023

Several Options Remain For Cidara’s Flu Candidate After J&J Halts Development

Jul 21 2023

Sanofi Adds To Immunology Pipeline In Collaboration With Recludix

Jul 20 2023

Pieris Looks For Way Out After AstraZeneca Exits Respiratory Collaboration

Jul 19 2023

Ipsen's Desire For Dealmaking Burns Bright

Jul 31 2023

Aeglea Revives Fortunes By Joining Merck And Roivant In TL1A Drug Chase

Jun 23 2023

AstraZeneca Boosts Rare Disease Pipeline With Ionis Antisense Candidate

Dec 07 2021

Infinity And MEI Re-evaluate Business Plans After Merger Falls Through

Jul 24 2023

Related Companies

ProQR Therapeutics N.V.

Laboratoires Thea

Spyre Therapeutics, Inc.

Immedica Pharma AB

Ayala Pharmaceuticals, Inc.

BioSight Ltd.

Quince Therapeutics, Inc.

EryDel SpA

ImmunoBiochem Corporation

ImmunoGen, Inc.

LimmaTech Biologics AG

GSK plc

Wellcome Trust Sanger Institute

MaxCyte, Inc.

Prime Medicine, Inc.

Vyera Pharmaceuticals, LLC

Soluble Therapeutics, Inc.

Genfit SA

Mithra Pharmaceuticals SA

Searchlight Pharma Inc.

Ionis Pharmaceuticals, Inc.

Roche Holding AG

SQZ Biotechnologies Company

Altamira Therapeutics Ltd.

Additional Topics

Business Strategies Deals M & A Commercial Deal Watch BioPharmaceutical

More from Deal Watch

More from Deals

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window